Investigating the Role of Antigen Orientation on the Immune Response Elicited by Neisseria meningitidis Factor H Binding Protein on GMMA
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigating the Role of Antigen Orientation on the Immune Response Elicited by Neisseria meningitidis Factor H Binding Protein on GMMA
Authors
Keywords
-
Journal
Vaccines
Volume 10, Issue 8, Pages 1182
Publisher
MDPI AG
Online
2022-07-29
DOI
10.3390/vaccines10081182
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Orientation of Antigen Display on Self-Assembling Protein Nanoparticles Influences Immunogenicity
- (2021) Cosette G. Schneider et al. Vaccines
- GMMA-Based Vaccines: The Known and The Unknown
- (2021) Francesca Mancini et al. Frontiers in Immunology
- Generalized Modules for Membrane Antigens as Carrier for Polysaccharides: Impact of Sugar Length, Density, and Attachment Site on the Immune Response Elicited in Animal Models
- (2021) Francesca Micoli et al. Frontiers in Immunology
- Neisseria meningitidis Factor H Binding Protein Surface Exposure on Salmonella Typhimurium GMMA Is Critical to Induce an Effective Immune Response against Both Diseases
- (2021) Francesca Necchi et al. Pathogens
- GMMA as a ‘plug and play’ technology to tackle infectious disease to improve global health: context and perspectives for the future
- (2021) Diego Piccioli et al. Expert Review of Vaccines
- Novel Simple Conjugation Chemistries for Decoration of GMMA with Heterologous Antigens
- (2021) Di Benedetto Di Benedetto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- OMV Vaccines and the Role of TLR Agonists in Immune Response
- (2020) Francesca Mancini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bacterial outer membrane vesicles as a platform for biomedical applications: An update
- (2020) Min Li et al. JOURNAL OF CONTROLLED RELEASE
- Immunological fingerprint of 4CMenB recombinant antigens via protein microarray reveals key immunosignatures correlating with bactericidal activity
- (2020) E. Bartolini et al. Nature Communications
- GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines
- (2020) Francesca Micoli et al. Vaccines
- Emerging Technologies for Low‐Cost, Rapid Vaccine Manufacture
- (2019) Zoltán Kis et al. Biotechnology Journal
- Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: A systematic review and meta-analysis
- (2019) Ali Purmohamad et al. MICROBIAL PATHOGENESIS
- Investigation on Sugar–Protein Connectivity in Salmonella O-Antigen Glycoconjugate Vaccines
- (2018) Gianluigi De Benedetto et al. BIOCONJUGATE CHEMISTRY
- Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes
- (2018) M. Giuliani et al. Scientific Reports
- Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants
- (2018) Kuang Tan et al. Frontiers in Microbiology
- Meningococcal B vaccine (4CMenB): the journey from research to real world experience
- (2018) Rino Rappuoli et al. Expert Review of Vaccines
- Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1
- (2017) Arianna Marini et al. PLoS One
- Beyond antigens and adjuvants: formulating future vaccines
- (2016) Tyson J. Moyer et al. JOURNAL OF CLINICAL INVESTIGATION
- Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines
- (2016) Naomi Benne et al. JOURNAL OF CONTROLLED RELEASE
- Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older
- (2016) PEDIATRICS
- Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®)
- (2016) Ashesh Gandhi et al. POSTGRADUATE MEDICINE
- Self-assembling protein nanoparticles in the design of vaccines
- (2016) Jacinto López-Sagaseta et al. Computational and Structural Biotechnology Journal
- Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection
- (2016) Weiwei Huang et al. Scientific Reports
- Outer membrane vesicles as platform vaccine technology
- (2015) Leo van der Pol et al. Biotechnology Journal
- Neisseria meningitidisfactor H-binding protein fHbp: a key virulence factor and vaccine antigen
- (2015) Kate L Seib et al. Expert Review of Vaccines
- Outer membrane vesicles as platform vaccine technology
- (2015) Leo van der Pol et al. Biotechnology Journal
- Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB
- (2015) Christiane Gerke et al. PLoS One
- A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on Generalized Modules for Membrane Antigens (GMMA)
- (2014) Oliver Koeberling et al. VACCINE
- Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties
- (2013) Agnese Faleri et al. FASEB JOURNAL
- Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa
- (2013) Rolando Pajon et al. PLoS One
- Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen
- (2013) Enrico Malito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Broadly Cross-Reactive Monoclonal Antibody Against an Epitope on the N-terminus of Meningococcal fHbp
- (2012) David M. Vu et al. Scientific Reports
- Immunization withSalmonella entericaSerovar Typhimurium-Derived Outer Membrane Vesicles Delivering the Pneumococcal Protein PspA Confers Protection against Challenge withStreptococcus pneumoniae
- (2010) Maneesha Muralinath et al. INFECTION AND IMMUNITY
- Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
- (2010) Han-Qing Jiang et al. VACCINE
- Solution Structure of the Factor H-binding Protein, a Survival Factor and Protective Antigen ofNeisseria meningitidis
- (2009) Francesca Cantini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
- (2009) Johan Holst et al. VACCINE
- Fine Antigenic Specificity and Cooperative Bactericidal Activity of Monoclonal Antibodies Directed at the Meningococcal Vaccine Candidate Factor H-Binding Protein
- (2008) P. T. Beernink et al. INFECTION AND IMMUNITY
- Binding of Complement Factor H (fH) to Neisseria meningitidis Is Specific for Human fH and Inhibits Complement Activation by Rat and Rabbit Sera
- (2008) D. M. Granoff et al. INFECTION AND IMMUNITY
- Complement‐Dependent Synergistic Bactericidal Activity of Antibodies against Factor H–Binding Protein, a Sparsely Distributed Meningococcal Vaccine Antigen
- (2008) Jo Anne Welsch et al. JOURNAL OF INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More